Washington, D.C.—Dr. Norman E. Sharpless, director of the National Cancer Institute, will serve as acting commissioner of the Food and Drug Administration, according to the New York Times, which cited an announcement by Alex M. Azar III, the secretary of Health and Human Services. Dr. Sharpless has been director of...
Washington, D.C.—Scott Gottlieb, commissioner of the Food and Drug Administration, announced his resignation, effective in April. The announcement came at the start of Expo West, causing much buzz and speculation as to what had led to the resignation—and what the impact would be for the natural products industry. The New...
Seattle, WA--Amazon.com Inc. has plans to open dozens of grocery stores across the U.S., according to a report from the Wall Street Journal (WSJ), which cited "people familiar with the matter" as the source. WSJ reported that Amazon is in talks to open stores in shopping centers in San Francisco, Seattle,...
Washington, D.C.—Duffy MacKay, N.D., who held the position of senior vice president of scientific and regulatory affairs at the Council for Responsible Nutrition, is departing CRN and taking up a position with CV Sciences, Inc., as its SVP of scientific and regulatory affairs, according to a press release. Andrew Shao,...
Washington, D.C.—Hemp and CBD are making the news again, this time thanks to potential legal and regulatory movement. Scott Gottlieb, M.D., commissioner of FDA, gave a speech at the National Association of State Departments of Agriculture (NASDA) Winter Policy Annual Conference on February 26th, in which he mentioned that NASDA...
Washington, D.C.—FDA Commissioner Scott Gottlieb, M.D., released a statement regarding the agency’s new efforts to strengthen regulation of dietary supplements, promising continued focus on safety and availability. The statement was largely positive. “I’ve personally benefited from the use of dietary supplements and, as a physician, recognize the benefits of certain...
As cannabidiol (CBD) fever sweeps the nation, some states are cracking down. As reported previously, South Dakota, Tennessee, and Illinois are all attempting to negotiate new laws around the sudden legality of CBD, while Oregon requested a clarification from the FDA on just what those laws are. FDA Commissioner Scott...
Pierre, SD--As WholeFoods previously reported, South Dakota's Senate Health and Human Services Committee was considering Senate Bill 22, which would have classified most CBD oil as a Schedule IV controlled substance. Following push back from the public and hemp activists about the generalized classification, the Committee amended the bill. According to a report in Rapid...
Dublin, OH—The Mid-American Health Organization (MAHO), a 15-state regional trade association committed to supporting the independent retail stores within the natural products industry, announced its separation from the Natural Products Association (NPA). MAHO’s new Bylaws, which were accepted by its Membership at its Annual Business Meeting on July 22, 2018,...
Issues surrounding the regulation of hemp and CBD on the state and federal levels have been dominating news headlines in January. Here, a glimpse at some of the latest: South Dakota: State Senate Bill 22 is scheduled for hearing on January 23. The issue to be discussed, according to Rapid City...
RSS
